Paulissen John M J, Zegers Catharina M L, Nijsten Iverna R, Reiters Pascalle H C M, Houben Ruud M, Eekers Daniëlle B P, Roelofs Erik
Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands.
Tech Innov Patient Support Radiat Oncol. 2022 Nov 1;24:107-112. doi: 10.1016/j.tipsro.2022.10.005. eCollection 2022 Dec.
Mobile health data capture applications (mHDA's) may improve communication between healthcare providers and patients. However, there is limited literature about the use of mHDA's facilitating clinical trials. In this study, the effectiveness of an application, supporting follow-up visits of cancer trial participants was investigated. Twenty participants were provided with an e-questionnaire via the mHDA. Participants rated the usability of the application as high performing (mean Systems Usability Scale 87 points). The research team rated the mHDA as highly applicable and efficient in preparing visits. Anamnesis, physical examination and agreement on further policy were performed within an average of 31 min.
移动健康数据采集应用程序（mHDA）可能会改善医疗服务提供者与患者之间的沟通。然而，关于使用mHDA促进临床试验的文献有限。在本研究中，对一款支持癌症试验参与者随访的应用程序的有效性进行了调查。通过mHDA为20名参与者提供了电子问卷。参与者将该应用程序的可用性评为高性能（系统可用性量表平均87分）。研究团队将mHDA评为在准备访视方面具有高度适用性和高效性。平均31分钟内完成了病史采集、体格检查以及关于进一步治疗方案的商定。
